Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
A sincere thanks to the almost 24,000 participants who attended this year's annual congress!
20 Sep 2017
Ontruzant is intended for the treatment of early and metastatic breast cancer, and metastatic gastric cancer
20 Sep 2017
ESMO, the leading European professional organisation for medical oncology announced today that Professor Fabrice André, MD, PhD, will be the new...
19 Sep 2017
It is intended for the maintenance treatment of ovarian cancer
18 Sep 2017
First approved biosimilar for the treatment of solid tumours
18 Sep 2017
The programme for Sarcoma & GIST 2018 is now available to download!
15 Sep 2017
Adolescents and young adult cancer patients have age-specific issues arising from their treatment
Zurich, Switzerland
13 Oct
- 14 Oct
2017
Munich, Germany
13 Oct
- 15 Oct
2017
Singapore
15 Nov
- 16 Nov
2017
Barcelona, Spain
16 Nov
- 19 Nov
2017
Singapore
17 Nov
- 19 Nov
2017
Singapore
20 Nov
- 21 Nov
2017
